摘要
肺炎支原体是小儿呼吸道感染最常见的病原体之一,由于其常常引起全身多脏器的损害而引起临床医生的重视,通过综述支原体肺炎的诊断进展、阿奇霉素治疗小儿支原体肺炎的疗效、不良反应及对不良反应的预防。可以得出外周血C-反应蛋白,PCT值与病情严重程度呈明显正相关性;阿奇霉素作为新一代大环内酯类抗生素,在临床上仍是治疗支原体肺炎的一线用药,但胃肠道反应明显,通过研究得出山莨菪碱对缓解胃肠道反应有效。
Mycoplasma pneumoniae is one of the most common pathogens in children with respiratory tract infection, and it is paid more attention by clinicians because it often causes damage to multiple organs of the whole body, through the review of diagnosis and treatment of mycoplasma pneumonia, the effect and adverse reaction of azithromycin in treatment of mycoplasma pneumonia in children and the prevention of adverse reactions. Peripheral blood C- reactive protein could be obtained, and the PCT value was positively correlated with the severity of the disease, azithromycin as a new generation of large ring of antibiotics, in the clinical treatment of mycoplasma pneumonia is still first-line treatment, but the gastrointestinal tract reaction is obvious, through the study on relieving gastrointestinal reaction from anisodamine effectively.
出处
《中国继续医学教育》
2016年第27期127-128,共2页
China Continuing Medical Education
关键词
支原体肺炎
阿奇霉素
不良反应
Mycoplasma pneumonia
Azithromycin
Adverse reaction
